FGFR And Its Role In Treating Squamous Cell Lung Cancer GRACEcast ALL Subjects Audio And Video podcast

Artwork

Player FM - Internet Radio Done Right

nine 年前已添加！

内容由cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD提供。所有播客内容（包括剧集、图形和播客描述）均由 cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

S

State Secrets: Inside The Making Of The Electric State

State Secrets: Inside The Making Of The Electric State podcast artwork

State Secrets: Inside The Making Of The Electric State podcast artwork

1
The Secret To Getting Inspired: Millie Bobby Brown & Chris Pratt Go Behind The Scenes 21:04

9天之前21:04

21:04

Step into the mysterious and visually stunning world of The Electric State as host Francesca Amiker takes you behind the scenes with the creative masterminds who brought Simon Stålenhag’s dystopian vision to life. In this premiere episode, directors Joe and Anthony Russo, stars Millie Bobby Brown and Chris Pratt, writers Christopher Markus and Stephen McFeely, and producers Angela Russo-Otstot and Chris Castaldi reveal how they transformed a haunting graphic novel into an epic cinematic experience. Watch The Electric State coming to Netflix on March 14th. Check out more from Netflix Podcasts . State Secrets: Inside the Making of The Electric State is produced by Netflix and Treefort Media.…

GRACEcast ALL Subjects audio and video « »
FGFR and Its Role in Treating Squamous Cell Lung Cancer

11年之前 2:21

分享

MP4•单集首页

内容由cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD提供。所有播客内容（包括剧集、图形和播客描述）均由 cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

Fibroblast growth factor receptor (FGFR) mutations may play a role in the growth of squamous cell lung cancer. Dr. Jonathan Riess talks about what they are learning in this area.

… continue reading

307集单集

Artwork

FGFR and Its Role in Treating Squamous Cell Lung Cancer

GRACEcast ALL Subjects audio and video

published 11年之前

分享

MP4•单集首页

内容由cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD提供。所有播客内容（包括剧集、图形和播客描述）均由 cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

Fibroblast growth factor receptor (FGFR) mutations may play a role in the growth of squamous cell lung cancer. Dr. Jonathan Riess talks about what they are learning in this area.

… continue reading

307集单集

Semua episod

×

1
Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy? 4:36

11 years之前4:36

4:36

Dr. Nasser Hanna outlines the possible benefits of consolidation chest radiation for small cell lung cancer patients who respond well to chemotherapy.

1
Management of Rare Kidney Tumors 1:55

11 years之前1:55

1:55

What puts you at risk for inherited kidney cancer? Dr. Nizar Tannir discusses the signs doctors look for to determine if a kidney cancer patient should be screened for a familial syndrome.

1
Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation? 5:28

11 years之前5:28

5:28

The doctors discuss the circumstances under which small cell lung cancer patients should receive prophylactic cranial irradiation.

1
NanoString Treatment for Kidney Cancer 2:03

11 years之前2:03

2:03

NanoString Technology may help doctors learn what is driving tumor growth in kidney cancer patients and, therefore, determine what treatments may be most effective for them.

1
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer? 2:27

11 years之前2:27

2:27

Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.

1
How is the Heng Criteria Applied to Kidney Cancer Patients? 4:40

11 years之前4:40

4:40

Dr. Daniel Heng is the namesake of the Heng Criteria, which evaluates various factors of kidney cancer patients to determine their prognoses.

1
Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment? 7:28

11 years之前7:28

7:28

The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had mixed feelings about the results.

1
What is PD1 and PDL1 in Kidney Cancer? 3:15

11 years之前3:15

3:15

Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer.

1
Zykadia for ALK Positive Lung Cancer: New Drug, New Hope 7:22

11 years之前7:22

7:22

The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.

1
No Clear Answer for Non-Clear Cell Kidney Cancer 5:41

11 years之前5:41

5:41

Drugs in early stage clinical trials seem to show benefit for non-clear cell kidney cancer, but more trials must take place and patients are desperately needed to enroll in them.

1
What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer 3:52

11 years之前3:52

3:52

"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).

1
Treating Newly Diagnosed Kidney Cancer 3:09

11 years之前3:09

3:09

Dr. Guru Sonpavde discusses what he does when he first begins treating a patient recently diagnosed with late stage kidney cancer.

1
MET-Amplified Lung Cancer: A New Target for XALKORI? 7:18

11 years之前7:18

7:18

Lung cancer patients with high MET amplification appear to do well on Xalcori (crizotinib), a drug that is approved for ALK positive patients.

1
The Hottest Thing in Late Stage Kidney Cancer 2:35

11 years之前2:35

2:35

Patients are responding very well to the next generation of immunotherapy drugs currently in clinical trials to treat kidney cancer.

1
CO1686 - 3rd Generation Drug for Acquired Resistance in EGFR Lung Cancer 4:10

11 years之前4:10

4:10

Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side effect concerns some.

欢迎使用Player FM

Player FM正在网上搜索高质量的播客，以便您现在享受。它是最好的播客应用程序，适用于安卓、iPhone和网络。注册以跨设备同步订阅。

收听超过500个主题

边探索边听这个节目